ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

NCT07037420 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: ALXN2420
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.